Similar articles

• Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization.

  Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, Aquilina M, Baldazzi F, Silenzi S, Cooke RM, Reggiani ML, Branzi A. Ortolani P, et al. Catheter Cardiovasc Interv. 2007 May 1;69(6):790-8. doi: 10.1002/ccd.21011. Catheter Cardiovasc Interv. 2007. PMID: 17290437 Clinical Trial.
• Gender medicine and drug eluting coronary stents.

  Kornowski R. Kornowski R. Catheter Cardiovasc Interv. 2010 Nov 15;76(6):814-6. doi: 10.1002/ccd.22850. Catheter Cardiovasc Interv. 2010. PMID: 21104730 No abstract available.
• Stent strut fracture: seeing is believing.

  Carter AJ. Carter AJ. Catheter Cardiovasc Interv. 2008 Apr 1;71(5):619-20. doi: 10.1002/ccd.21569. Catheter Cardiovasc Interv. 2008. PMID: 18360854 No abstract available.
• The current status of stent placement in small coronary arteries < 3.0 mm in diameter.

  Lau KW, Hung JS, Sigwart U. Lau KW, et al. J Invasive Cardiol. 2004 Aug;16(8):411-6. J Invasive Cardiol. 2004. PMID: 15282416 Review.
• Should the left main be covered entirely with drug-eluting stents in percutaneous intervention.

  Lozano I, Avanzas P, Moris C. Lozano I, et al. J Invasive Cardiol. 2006 Nov;18(11):E276-8. J Invasive Cardiol. 2006. PMID: 17090829 Review.